as on March 13, 2026 at 6:59 am IST
Day's Low
Day's High
0.17%
Downside
3.10%
Upside
52 Week's Low
52 Week's High
57.49%
Downside
27.37%
Upside
Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$35.5B
EPS (TTM)
2.6808
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.40%
PE Ratio (TTM)
25.18
Industry PE ratio
17.7675641025641
PEG Ratio
1.5166
EBITDA
5.0B
Revenue (TTM)
17.3B
Profit Margin
8.17%
Return On Equity TTM
20.79%
Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.
Teva Pharmaceutical Industries Ltd in the last 5 years
Lowest (3.34x)
March 31, 2022
Industry (17.77x)
March 13, 2026
Today (25.18x)
March 13, 2026
Highest (12.90x)
December 31, 2024
Today’s Price to Earnings Ratio: 25.18x
Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $35.5B | 171.55% | 25.18 | 8.17% | ||
| BUY | $23.4B | NA | 19.15 | 41.94% | |
| HOLD | $16.1B | -3.9% | -21.95 | -24.58% | |
| BUY | $44.5B | NA | 20.83 | 15.11% | |
| BUY | $52.8B | -24.32% | 20 | 28.24% |
The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Teva Pharmaceutical Industries Ltd investment value today
Current value as on today
₹1,83,918
Returns
₹83,918
(+83.92%)
Returns from Teva Pharmaceutical Industries Ltd Stock
₹78,129 (+78.13%)
Dollar Returns*
₹5,789 (+5.79%)
Based on 9 analysts
0.00%
Buy
33.33%
Hold
66.67%
Sell
Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $38.14
Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.
What analysts predicted
23.13%UPSIDE
Target Price
$38.14
Current Price
$29.32
Analyzed by
9 Analysts
Target
$38.14
Teva Pharmaceutical Industries Ltd target price $38.14, a slight upside of 23.13% compared to current price of $29.32. According to 9 analysts rating.
Search interest for Teva Pharmaceutical Industries Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 25 February
Wed, 07:42 PM
-Federal Circuit Court rules in favor of Teva, allowing marketing of generic Korlym.
Wed, 08:10 PM
-Teva Pharmaceutical Industries Ltd. holds a Zacks Rank of #2 (Buy) with improving earnings estimates.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Teva Pharmaceutical Industries Ltd has shown consistent improvement in its net profit over the last 7 quarters. The net profit has increased from a loss of $846.0 million to a profit of $480.0 million. This represents an average quarterly increase of 77.5%, indicating a strong upward trend in the company's profitability.
Revenue Rich
![]()
Teva Pharmaceutical Industries Ltd has shown positive revenue growth over the last four quarters, with revenues increasing from $3.89 billion to $4.71 billion. This represents an average increase of 6.2% in revenue each quarter.
Price Rise
![]()
In the last 6 months, TEVA stock has moved up by 47.0%
Best in 3 Years
![]()
In the last 3 years, TEVA has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, TEVA has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Teva Pharmaceutical Industries Ltd |
| Headquarters | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
| Industry | Health Technology |
| CEO | Mr. Richard D. Francis |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer |
Mr. Matthew Shields | Executive Vice President of Global Operations |
Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |
Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer |
Mr. Placid Jover | Executive VP & CHRO |
Mr. Richard D. Francis | President, CEO & Director |
Mr. Richard Gordon Daniell | Executive Vice President of European Commercial |
Ms. Christine Fox | Executive VP of US Commercial & Head of Innovative Franchise |
Mr. Amir Weiss | Senior VP & Chief Accounting Officer |
Mr. Eliyahu Sharon Kalif | Executive VP & CFO |
Teva Pharmaceutical Industries Ltd share price today is $29.32 as on at the close of the market. Teva Pharmaceutical Industries Ltd share today touched a day high of $30.23 and a low of $29.27.
Teva Pharmaceutical Industries Ltd share touched a 52 week high of $37.35 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is closed at $29.32,which is 21.49% down from its 52 week high and 135.22% up from its 52 week low.
Teva Pharmaceutical Industries Ltd market capitalisation is $0.04T as on .
Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹92.206 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹922.06 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Teva Pharmaceutical Industries Ltd share’s latest price of $29.32 as on March 13, 2026 at 1:29 am IST, you will get 0.3411 shares of Teva Pharmaceutical Industries Ltd. Learn more about
fractional shares .
Teva Pharmaceutical Industries Ltd stock has given 171.55% share price returns and 26.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?